Scinai Immunotherapeutics .(SCNI) - Prospectus

As filed with the Securities and Exchange Commission on October 30, 2023. Registration No. 333-_________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) Puglisi & Associates 850 Library Avenue, Suite 204 Newark, Delaware +1 (302) 738-6680 Scinai Immunotherapeutics Ltd. (Exact Name of Registrant as Specif ...